Bliss GVS Pharma (BOM:506197) Inventories, Raw Materials & Components: ₹580 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:506197 Bliss GVS Pharma Ltd BOM:506197
57 GF Score
Price ₹482.50
GF Value ₹151.86
Valuation Significantly Overvalued
! 5 Warning Signs
View Full Analysis

What is Bliss GVS Pharma Inventories, Raw Materials & Components?

Bliss GVS Pharma BOM:506197 -4.24% 57 Inventories, Raw Materials & Components is ₹580 Mil as of Mar. 2026. GuruFocus rates BOM:506197 with a GF Score™ of 57/100 and a GF Value™ of ₹151.86 (Significantly Overvalued). The stock has 5 warning signs investors should review.

Bliss GVS Pharma's inventories, raw materials & components for the quarter that ended in Mar. 2026 was ₹580 Mil.

Bliss GVS Pharma's quarterly raw materials stayed the same from Sep. 2025 (₹0 Mil) to Dec. 2025 (₹0 Mil) but then increased from Dec. 2025 (₹0 Mil) to Mar. 2026 (₹580 Mil).

Bliss GVS Pharma's annual raw materials increased from Mar. 2024 (₹554 Mil) to Mar. 2025 (₹558 Mil) and increased from Mar. 2025 (₹558 Mil) to Mar. 2026 (₹580 Mil).

Bliss GVS Pharma Inventories, Raw Materials & Components Historical Data

* Premium members only.

The historical data trend for Bliss GVS Pharma's Inventories, Raw Materials & Components can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bliss GVS Pharma Inventories, Raw Materials & Components Chart

Bliss GVS Pharma Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Inventories, Raw Materials & Components
Get a 7-Day Free Trial Premium Member Only Premium Member Only 439.53 498.58 553.59 558.50 580.09

Bliss GVS Pharma Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Inventories, Raw Materials & Components Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 558.50 0.00 0.00 0.00 580.09
BOM:506197
57GF Score
Bliss GVS Pharma Ltd BOM:506197
Inventories, Raw Materials & Components is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Bliss GVS Pharma Inventories, Raw Materials & Components Calculation

Materials and components scheduled for use in making a product.

What does a Inventories, Raw Materials & Components of ₹580 Mil mean?
Bliss GVS Pharma (BOM:506197) has a Inventories, Raw Materials & Components of ₹580 Mil as of Mar. 2026. Raw materials are the components a company uses for its main products. View historical data on Bliss GVS Pharma and its competitors.
Is Bliss GVS Pharma's Inventories, Raw Materials & Components too high?
Bliss GVS Pharma's current Inventories, Raw Materials & Components is ₹580 Mil. Overall, Bliss GVS Pharma has a GF Score™ of 57/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Bliss GVS Pharma's Inventories, Raw Materials & Components compare to ZTS and UTHR?
Bliss GVS Pharma's Inventories, Raw Materials & Components of ₹580 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Inventories, Raw Materials & Components for a Drug Manufacturers company?
A good Inventories, Raw Materials & Components depends on the Drug Manufacturers industry context. However, Inventories, Raw Materials & Components should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Inventories, Raw Materials & Components mean?
A high Inventories, Raw Materials & Components can signal that a stock is expensive relative to its fundamentals. Raw materials are the components a company uses for its main products. View historical data on Bliss GVS Pharma and its competitors. Bliss GVS Pharma's current Inventories, Raw Materials & Components is ₹580 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bliss GVS Pharma stock overvalued right now?
Based on GuruFocus' analysis, Bliss GVS Pharma (BOM:506197) is currently considered Significantly Overvalued. The stock's GF Value™ is ₹151.86, compared to a current price of ₹482.50 — trading 217.7% above its estimated fair value. The current Inventories, Raw Materials & Components is ₹580 Mil. Bliss GVS Pharma's overall GF Score™ is 57/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Inventories, Raw Materials & Components calculated?
Inventories, Raw Materials & Components is calculated from a company's financial statements. For Bliss GVS Pharma (BOM:506197), the current Inventories, Raw Materials & Components is ₹580 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Bliss GVS Pharma (BOM:506197) Overvalued in 2026?

Based on GuruFocus' analysis, Bliss GVS Pharma stock appears to be overvalued. The current stock price of ₹482.50 is trading 217.7% above its estimated GF Value™ of ₹151.86. GuruFocus considers Bliss GVS Pharma to be Significantly Overvalued.

Key valuation signals for BOM:506197:

  • Inventories, Raw Materials & Components: ₹580 Mil
  • GF Value™: ₹151.86 vs. price of ₹482.50 (217.7% above fair value)
  • GF Score™: 57/100 with 5 warning signs

No single metric tells the full story. See the BOM:506197 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Bliss GVS Pharma Business Description

Other Exchanges BLISSGVS:India
Address Saki Vihar Road, 102, Hyde Park, Andheri (East), Mumbai, MH, IND, 400072
Bliss GVS Pharma Ltd is an India-based company engaged in the manufacturing, marketing, trading, and export of pharmaceutical products. Some of its brands include Lonart, P-Alaxin, Funbact, and Lofnac, and others. It offers pharma products including tablets, suspensions, suppositories, and injections. The majority of its revenue is derived from Exports.
57GF Score

Get the complete analysis for BOM:506197

Inventories, Raw Materials & Components is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹482.50
Price
₹151.86
GF Value